BioCentury
ARTICLE | Clinical News

Bondronat ibandronic acid regulatory update

August 4, 2003 7:00 AM UTC

The EMEA's CPMP recommended that the indication for Bondronat include prevention of skeletal events (pathological fractures, bone complications requiring radiotherapy or surgery) in patients with brea...